Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots

por Abrahamsson, Per-Anders
Publicado 2017

Androgen deprivation therapy and side effects: are GnRH antagonists safer?

por Freedland, Stephen J, Abrahamsson, Per-Anders
Publicado 2020

Editorial for the Abstracts of the 20th Meeting of the Association of Academic European Urologists [European Urology Open Science 2023;48(Suppl 1):S1–48]()

por Heesakkers, John, Debruyne, Frans, Abrahamsson, Per-Anders
Publicado 2023

HIF1α isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation

por Monsef, Nastaran, Soller, Maria, Panagopoulos, Ioannis, Abrahamsson, Per Anders
Publicado 2010

Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer

por Tinzl, Martina, Chen, Binshen, Chen, Shao-Yong, Semenas, Julius, Abrahamsson, Per-Anders, Dizeyi, Nishtman
Publicado 2013

Correction: Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer

por Tinzl, Martina, Chen, Binshen, Chen, Shao-Yong, Semenas, Julius, Abrahamsson, Per-Anders, Dizeyi, Nishtman
Publicado 2018

Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions

por Gobbo, Marina G., Dizeyi, Nishtman, Abrahamsson, Per-Anders, Bertilsson, Per-Anders, Masitéli, Viviane Sanches, Pytlowanciv, Eloisa Zanin, Taboga, Sebastião R., Góes, Rejane M.
Publicado 2015

Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells

por Sarwar, Martuza, Semenas, Julius, Miftakhova, Regina, Simoulis, Athanasios, Robinson, Brian, Wingren, Anette Gjörloff, Mongan, Nigel P., Heery, David M., Johnsson, Heather, Abrahamsson, Per-Anders, Dizeyi, Nishtman, Luo, Jun, Persson, Jenny L.
Publicado 2016

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up

por Johnson, Heather, Guo, Jinan, Zhang, Xuhui, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan H. B., Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Kenner, Lukas, Feng, Xiaoyan, Zou, Chang, Xiao, Kefeng, Persson, Jenny L., Chen, Lingwu
Publicado 2020

A 23‐Gene Classifier urine test for prostate cancer prognosis

por Guo, Jinan, Johnson, Heather, Zhang, Xuhui, Feng, Xiaoyan, Zhang, Heqiu, Simoulis, Athanasios, Wu, Alan HB, Xia, Taolin, Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per‐Anders, Kenner, Lukas, Chen, Lingwu, Zhong, Wanmei, Xiao, Kefeng, Persson, Jenny L., Zou, Chang
Publicado 2021

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients

por Guo, Jinan, Zhang, Xuhui, Xia, Taolin, Johnson, Heather, Feng, Xiaoyan, Simoulis, Athanasios, Wu, Alan H. B., Li, Fei, Tan, Wanlong, Johnson, Allan, Dizeyi, Nishtman, Abrahamsson, Per-Anders, Kenner, Lukas, Xiao, Kefeng, Zhang, Heqiu, Chen, Lingwu, Zou, Chang, Persson, Jenny L.
Publicado 2021

A Festschrift in Honor of Edward M. Messing, MD, FACS

por Joseph, Jean V., Brasacchio, Ralph, Fung, Chunkit, Reeder, Jay, Bylund, Kevin, Sahasrabudhe, Deepak, Yeh, Shu Yuan, Ghazi, Ahmed, Fultz, Patrick, Rubens, Deborah, Wu, Guan, Singer, Eric, Schwarz, Edward, Mohile, Supriya, Mohler, James, Theodorescu, Dan, Lee, Yi Fen, Okunieff, Paul, McConkey, David, Rashid, Hani, Chang, Chawnshang, Fradet, Yves, Guru, Khurshid, Kukreja, Janet, Sufrin, Gerald, Lotan, Yair, Bailey, Howard, Noyes, Katia, Schwartz, Seymour, Rideout, Kathy, Bratslavsky, Gennady, Campbell, Steven C., Derweesh, Ithaar, Abrahamsson, Per-Anders, Soloway, Mark, Gomella, Leonard, Golijanin, Dragan, Svatek, Robert, Frye, Thomas, Lerner, Seth, Palapattu, Ganesh, Wilding, George, Droller, Michael, Trump, Donald
Publicado 2018